Assessment of HIV risk.

Based on the review of existing instruments and analysis of problems encountered in clinical and research practice with one of the most commonly used assessment instruments, the RAB, this paper proposes a number of solutions aimed at improving validity, and efficiency of assessment of HIV risk in drug abusing populations. Briefly, five domains of assessment are discussed: intravenous drug use, high-risk sexual behaviors, knowledge of HIV transmission and methods of prevention, psychological aspects of behavioral change, and epidemiological factors of HIV transmission. The paper discusses also changes in format, scope, and context, as well as scoring procedures that may improve discriminability and sensitivity to detect change of a comprehensive HIV risk assessment instrument. Finally, a process of developing an HIV risk assessment instrument, the ARI-I, which is based on the proposed recommendations and which incorporates methodological improvements discussed in the paper is briefly described.

[1]  D. Vlahov,et al.  Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[2]  S. Holmberg,et al.  Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. , 1996, Drug and alcohol dependence.

[3]  J. Goedert,et al.  Mortality among drug users in the AIDS era. , 1995, International journal of epidemiology.

[4]  M. Iguchi,et al.  Prospective evaluation of a model of risk for HIV infection among injecting drug users. , 1995, Drug and alcohol dependence.

[5]  M. Chiasson,et al.  Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. , 1995, American journal of public health.

[6]  R. Brooner,et al.  Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. , 1995, Drug and alcohol dependence.

[7]  C. Morrison,et al.  The validity of behavioral data reported by injection drug users on a clinical risk assessment. , 1995, The International journal of the addictions.

[8]  M. Doyle,et al.  HIV infection and associated sexually transmitted diseases in women. , 1995, Texas medicine.

[9]  S. Holmberg,et al.  Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. , 1994, The New England journal of medicine.

[10]  J. Watters,et al.  HIV Infection Among Female Injection‐Drug Users Recruited in Community Settings , 1994, Sexually transmitted diseases.

[11]  I. Onorato,et al.  HIV infection among non‐injecting drug users entering drug treatment, United States, 1989–1992 , 1994 .

[12]  S. Tortu,et al.  The risk of HIV infection in a national sample of women with injection drug-using partners. , 1994, American journal of public health.

[13]  D. Calsyn,et al.  Reporting of HIV risk behaviors by injection drug using heterosexual couples in methadone maintenance. , 1994, Drug and alcohol dependence.

[14]  Kall Ki.  The risk of HIV infection for noninjecting sex partners of injecting drug users in Stockholm. , 1994 .

[15]  C. Blanton,et al.  AIDS and Intravenous Drug Use: A Growing Menace , 1994, Journal of drug education.

[16]  H. Kushner,et al.  Interpreting HIV seroprevalence data from a street-based outreach program. , 1994, Journal of acquired immune deficiency syndromes.

[17]  R. Baxter,et al.  Correlates of HIV Seropositivity among Injection Drug Users Not in Treatment , 1992 .

[18]  I. Onorato,et al.  HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. The Field Services Branch of the Centers for Disease Control. , 1992, American journal of public health.

[19]  N. Heather,et al.  The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. , 1991, AIDS.

[20]  D. Lauver,et al.  HIV risk status and preventive behaviors among 17,619 women. , 1995, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[21]  W. Compton,et al.  Results of the NIDA treatment demonstration grants' cocaine workgroup: characteristics of cocaine users and HIV risk behaviors. , 1995, Drug and alcohol dependence.

[22]  M. Ross,et al.  HIV risk exposure of injecting drug users in Sydney. , 1995, Drug and alcohol review.

[23]  M. Iguchi,et al.  Cocaine use and HIV risk behavior in methadone maintenance patients. , 1995, Drug and alcohol dependence.

[24]  A. Stoddard,et al.  Cocaine use and risky injection and sexual behaviors. , 1995, Drug and alcohol dependence.

[25]  D. Simpson,et al.  HIV risks, gender, and cocaine use among opiate users. , 1995, Drug and alcohol dependence.

[26]  S. E. Wugalter,et al.  Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. , 1995, Drug and alcohol dependence.

[27]  N. Mckeganey,et al.  Why do men buy sex and what are their assessments of the HIV-related risks when they do? , 1994, AIDS care.

[28]  D. Richardson,et al.  A comparison of HIV risk between women and men who inject drugs. , 1994, AIDS education and prevention : official publication of the International Society for AIDS Education.

[29]  M. Anglin,et al.  Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners. , 1994, The International journal of the addictions.

[30]  S. O'Malley,et al.  Decline in intravenous drug use among treatment-seeking opiate users. , 1993, Journal of substance abuse treatment.